As of today, intrinsic value of Vertex Pharmaceuticals Incorporated is $323.5.
As of today, Vertex Pharmaceuticals Incorporated is overvalued by 30.9%, compared to the current market share price of $468.1.
As of today, Vertex Pharmaceuticals Incorporated has a stock rating of 7 (out of 10), which is considered Great.
As of today, Vertex Pharmaceuticals Incorporated has a Great stock rating, which is 30.9% overvalued. According to Value Sense backtesting, stocks with similar profile tend to outperform the market by 0.5%.